Arcellx (NASDAQ: ACLX) — T. Rowe Price reports 4.5% holding in 13G/A
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Arcellx Inc. Schedule 13G/A discloses that T. Rowe Price Investment Management, Inc. beneficially owned 2,653,848 shares of Arcellx common stock, representing 4.5% of the class as of 02/28/2026. The filing states sole voting power of 2,503,059 shares and sole dispositive power of 2,647,494. Item 5 notes ownership of 5 percent or less of a class.
Positive
- None.
Negative
- None.
FAQ
What did T. Rowe Price report for ACLX in the Schedule 13G/A?
Direct answer: T. Rowe Price reported beneficial ownership of 2,653,848 shares (4.5%) of Arcellx common stock as of 02/28/2026. Context: The filing lists sole voting power of 2,503,059 and sole dispositive power of 2,647,494.
Does the filing indicate T. Rowe Price controls more than 5% of ACLX?
Direct answer: No, the filing indicates ownership of 4.5%, which is under 5 percent. Context: Item 5 expressly states "Ownership of 5 percent or less of a class," and the cover shows the 4.5% figure.
What date is the ownership in the ACLX Schedule 13G/A measured as of?
Direct answer: The filing lists the measurement date as 02/28/2026. Context: The amendment header shows that date and the signature block is dated 03/06/2026, consistent with the Schedule 13G/A amendment timing.
Does the Schedule 13G/A imply beneficial ownership by an individual at T. Rowe Price?
Direct answer: No, the filer is listed as T. Rowe Price Investment Management, Inc., a Maryland entity, not an individual. Context: The filing includes a corporate signature by a Vice President, and it disclaims admission of beneficial ownership in the text.